财务表现 - 分析师预计Charles River Laboratories (CRL) 下一季度每股收益为$2.05，同比下降26.3% [1] - 预计营收为$997.24百万美元，同比下降3.1% [1] - 'Revenues- Research Models and Services' 有望达到$202.98百万美元，同比增长1.6% [7] - 'Revenues- Discovery and safety assessment' 预计将达到$625.40百万美元，同比下降5.6% [7] - 'Revenues- Manufacturing support' 预计将达到$169.61百万美元，同比增长1.4% [8] - 'Revenues- Services' 预计将达到$834.54百万美元，同比下降2.7% [9] - 'Revenues- Products' 预计将达到$162.38百万美元，同比下降5.6% [10] - 'Operating income- Research Models and Services Non-GAAP' 预计将达到$49.89百万美元，较上一年同期的$46.73百万美元有所增长 [10] - 'Operating income- Discovery and safety assessment - Non-GAAP' 预计将达到$146.73百万美元，较去年同期的$191.97百万美元有所下降 [11]